Reported Reactions

Devices › Tricuspid valve repair device, percutaneously delivered

Device brand name · Tricuspid valve repair device percutaneously delivered

TriClip Delivery System (TCDS): medical device reports filed with FDA

240 reports name it, 2024–2026. Manufacturer given most often on reports: Abbott Medical. Product code NPS.

240
device reports naming the brand
0% of all MAUDE reports · about 111 a year
118
reports, 12 months to August 2026
91 in the 12 months before
13.3%
classified as malfunction
35% across the product code
29.6%
classified as death, as reported
71 reports · not verified by FDA

240 medical device reports received by FDA name the brand "TriClip Delivery System (TCDS)" (tricuspid valve repair device percutaneously delivered); the manufacturer given most often on reports is Abbott Medical; received from May 2024 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

118 reports arrived in the 12 months to August 2026, up 30% from 91 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (57.1%), death (29.6%) and malfunction (13.3%); across all tricuspid valve repair device, percutaneously delivered reports (product code NPS) death is recorded in 3.8% and malfunction in 35%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are incomplete coaptation (23.3%), migration (3.3%) and difficult or delayed positioning (1.7%). The patient problems coded most often are heart failure/congestive heart failure, tricuspid valve insufficiency/ regurgitation and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01020Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 7Jun 2024: 15Jul 2024: 5Aug 2024: 4Sep 2024: 5Oct 2024: 7Nov 2024: 8Dec 2024: 82025Jan 2025: 4Feb 2025: 10Mar 2025: 10Apr 2025: 6May 2025: 5Jun 2025: 6Jul 2025: 11Aug 2025: 11Sep 2025: 11Oct 2025: 7Nov 2025: 8Dec 2025: 122026Jan 2026: 9Feb 2026: 6Mar 2026: 3Apr 2026: 20May 2026: 10Jun 2026: 10Jul 2026: 9Aug 2026: 13

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0511012024: 5920242025: 10120252026: 802026

Event type and report source

Event type, as classified on the report

Death29.6%71
Injury57.1%137
Malfunction13.3%32
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%240
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 2,117 reports carrying product code NPS. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Incomplete coaptation5623.3%41%
Migrationthe device moved from where it was placed83.3%5.8%
Difficult or delayed positioning41.7%7.7%
Expulsion41.7%1.7%
Insufficient device problem information41.7%0.2%
Activation failure31.3%0.3%
Positioning failure31.3%4.3%
Device damaged by another device20.8%7.1%
Physical resistance/sticking20.8%1.8%
Difficult to insertthe device was hard to insert10.4%0.4%
Difficult to removethe device was hard to remove10.4%6.7%
Entrapment of device10.4%7.8%
Improper or incorrect procedure or method10.4%2%
Material deformation10.4%0.7%
Material split, cut or torn10.4%0.8%
Off-label use10.4%0.2%
Retraction problem10.4%0.6%
Unintended movement10.4%8.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Heart failure/congestive heart failure9137.9%
Tricuspid valve insufficiency/ regurgitation7932.9%
Hemorrhage/blood loss/bleeding2410%
Renal failurekidney failure218.8%
Dyspneashortness of breath187.5%
Stroke/cva114.6%
Arrhythmia104.2%
Cardiac arrestthe heart stopped72.9%
Cardiac tamponade62.5%
Myocardial infarctionheart attack62.5%
Swelling/ edema62.5%
Atrial fibrillationan irregular heart rhythm52.1%
Respiratory failurethe lungs could not supply enough oxygen52.1%
Fatiguetiredness41.7%
Foreign body in patientpart of a device left in the patient41.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTriClip Delivery System (TCDS)Product code NPSAll MAUDE reports
Reports2402,11726,136,888
Share of that pool—11.3%0%
Classified as death, per 1,000 reports296389
Classified as injury57.1%61.1%36.2%
Classified as malfunction13.3%35%62.3%
Filed by the manufacturer100%99.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NPS

BrandReportsLatest 12 monthsClassified as death
TriClip G4 System1,3683870.7%
TriClip G5 Delivery System5024760%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about TriClip Delivery System (TCDS) reports

How many FDA reports name TriClip Delivery System (TCDS)?

240 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 118 in the latest 12 months.

What kinds of events are reported?

injury (57.1%), death (29.6%) and malfunction (13.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

incomplete coaptation (23.3%), migration (3.3%), difficult or delayed positioning (1.7%), expulsion (1.7%) and insufficient device problem information (1.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that TriClip Delivery System (TCDS) was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.